Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • ECG Review: Chest Pain in a 21 Year Old

    Clinical Scenario: The ECG in the Figure shows normal sinus rhythm at a rate of 80 beats/minute. The PR, QRS, and QT intervals are normal. There is an rSR pattern in lead III. The axis is +40°. There is no sign of chamber enlargement. The most remarkable finding on this tracing is the presence of subtle but real ST segment elevation in multiple leads including I, II, aVF, and V2 through V6.
  • Clinical Briefs

    Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients; Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease (COOPERATE): A Randomized Controlled Trial; Early Onset of Action and Efficacy of a Combination of Calcipotriene and Betamethasone Dipropionate in the Treatment of Psoriasis
  • C-Reactive Protein Hits the Big Time

    Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with beta-blockers or statins.
  • Full April 1, 2003 Issue in PDF

  • Getting men on board: one facility’s approach

    If the number of men on your patient rosters is low, take a look at the approach used by Planned Parenthood of San Antonio and South Central Texas. In the first year of its marketing initiative, the number of its male patients nearly doubled from 2% to 3.7% of total patients served.
  • Use the web for hormone therapy information

    Check out the following Internet resources for more information on hormone therapy.
  • Hormone therapy: Make decisions on a balanced risk-to-benefit basis

    Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.
  • CTU Updates

    Enter abstracts for ARHP annual conference; New payment options announced for Mirena
  • Ask the Experts: Answers to questions on OC use, DMPA impact

    Whats the impact of concomitant medications on combined oral contraceptives (OCs)?
  • The Pill and bone health: What is the impact?

    Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?